Search clinical trials for: Bevacizumab (adjuvant)

Total 10719 results

National Cancer Institute (NCI)

Completed

Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma

Recurrent Melanoma | Stage IV Melanoma

United States
University Medical Center Groningen

Not yet recruiting

Safety and Feasibility of Immuno-OCT (DETOUR)

Barrett Esophagus | Colon Carcinoma | Gastrointestinal Dysplasia
Fudan University

Recruiting

The Efficacy and Safety of Fruquintinib Plus Chemotherapy as Second-line Treatment in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
Fudan University

Recruiting

VIC Regimen Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Advanced Colorectal Cancer

Colorectal Cancer

China
Asociación para Evitar la Ceguera en México

Withdrawn

Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy

Central Serous Chorioretinopathy

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Efficacy of Retreatments With Intravitreal Bevacizumab

Age Related Macular Degeneration | Choroidal Neovascularization

Mexico
Massachusetts Eye and Ear Infirmary

Completed

Topical Avastin for Treatment of Corneal Neovascularization

Corneal Neovascularization

United States
Qilu Hospital of Shandong University
Renmin Hospital of Wuhan University; Moriggia-Pelascini Gravedona Hospital

Completed

Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia (BEST-CP)

Coronavirus Infections

China, Italy
University Hospital, Limoges

Completed

Efficacy and Safety Study of Avastin to Treat Neovascularisation of the Cornea (BECONNEC)

Corneal Newvessels

France
Biocad

Withdrawn

Evaluation the Pharmacokinetics, Safety, Tolerability of BCD-021 in Patients With Neovascular Age-related Macular Degeneration

Neovascular Age-related Macular Degeneration
University of Campania "Luigi Vanvitelli"

Completed

Intravitreal Bevacizumab in Agioid Streaks

Choroidal Neovascularization | Angioid Streaks

Italy
University of Alabama at Birmingham

Completed

The Effect of Bevacizumab (Avastin) on Pterygium

Pterygium

United States
Emory University
Genentech, Inc.

Withdrawn

Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First Therapy

Esophageal Carcinoma
Swiss Group for Clinical Cancer Research

Completed

Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Breast Cancer

Switzerland
Radboud University Medical Center
Institut Pasteur

Completed

Safety and Efficacy Study of Plasmodium Falciparum LSA-3 Malaria Vaccine (LSA-3-rec)

Healthy

Netherlands
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation...

Active, not recruiting

SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19 in Healthy Adults

SARS-CoV-2 Infection

United States
Affiris AG
University Hospital Tuebingen

Withdrawn

Study Assessing Tolerability and Safety and Exploring the Immunogenicity and Therapeutic Activity of AFFITOPE® PD01A in PD-GBA Patients

Parkinson's Disease

Germany
Immune Targeting Systems Ltd
INCResearch Australia Pty Limited

Completed

Safety, Tolerability and Immunogenicity of Two Different Formulations of an Influenza A Vaccine (FP-01.1)

Influenza A

Australia
Yonsei University

Completed

Adjuvant Hepatic Arterial Infusional Chemotherapy After Curative Resection of Hepatocellular Carcinoma

Hepatocellular Carcinoma

Korea, Republic of
University Medical Center Groningen
Dutch Cancer Society

Completed

Visualization of Rectal Cancer During Endoscopy, Using a Fluorescent Tracer (RAPIDO-TRACT)

Rectal Cancer

Netherlands
Case Comprehensive Cancer Center

Active, not recruiting

Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM

Glioblastoma

United States
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer

Recurrent Ovarian Cancer

China
Chongqing University Cancer Hospital

Recruiting

Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi

Ovarian Cancer

China
Hospices Civils de Lyon

Active, not recruiting

Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer (BEVANEC)

Neuroendocrine Carcinomas

France
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI); Genentech, Inc.

Completed

Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery

Liver Cancer

United States
Assistance Publique - Hôpitaux de Paris

Unknown

Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort (CORIMMUNO-BEVA)

COVID19 Pneumonia
University of California, San Diego

Completed

Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

Hereditary Hemorrhagic Telangiectasia (HHT)

United States
Boehringer Ingelheim

Completed

Pharmacokinetics and Safety Study of BI 695502 in Healthy Subjects

Healthy

New Zealand
Genentech, Inc.

Withdrawn

Efficacy and Safety Study of rhuMAb VEGF to Treat Metastatic Renal Cell Carcinoma

Renal Cell Cancer
Neon Hospital
Ondokuz Mayıs University

Completed

The Efficacy of Subconjunctival Bevacizumab in Diabetic Macular Edema

Diabetic Macular Edema
ARCAGY/ GINECO GROUP

Completed

First Line Metastatic Breast Cancer Treatment (ESMERALDA) (ESMERALDA)

Metastatic Breast Cancer

France
Children's Hospital Los Angeles

Temporarily not available

Use of Pan-Vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)

Retinopathy of Prematurity

United States
Dutch Colorectal Cancer Group
Sanofi; Roche Pharma AG; Koningin Wilhelmina Fonds; Immunicon

Completed

Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer

Colorectal Cancer

Netherlands
Taipei Medical University Hospital

Completed

Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast Cancer

Metastatic Breast Cancer

Taiwan
Asociación para Evitar la Ceguera en México

Terminated

Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks

Choroidal Neovascularization | Angioid Streaks

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Intravitreal Bevacizumab for Diabetic Retinopathy

Proliferative Diabetic Retinopathy | Severe Nonproliferative | Active Photocoagulated Diabetic Retinopathy

Mexico
West Penn Allegheny Health System

Withdrawn

Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab

Glioblastoma | Optic Neuropathy
University Medical Center Groningen

Completed

FLuoresence Image Guided Surgery With A VEGF-targeted Tracer in Soft-tissue Sarcomas in Humans Approach With Bevacizumab-IRDye 800CW (FLASH)

Soft Tissue Sarcoma

Netherlands
Sun Yat-sen University

Unknown

Sintilimab Combined With Bevacizumab for Brain Metastases From Non-small Cell Lung Cancer

Non Small Cell Lung Cancer | Bevacizumab | Brain Metastases | Sintilimab

China
Changhua Christian Hospital

Completed

Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor

Choroidal Neovascularization | Punctate Inner Choroidopathy

Taiwan
Beijing Hospital

Unknown

Effectiveness and Safety of Adding Bevacizumab to First Line Chemotherapy in Lung Cancer Patients With Stable Disease

Non-small Cell Lung Cancer Metastatic
Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Unknown

Pharmacokinetics and Safety Study of ASKB1202 in Chinese Healthy Subjects

Healthy
University of Zurich

Completed

Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases

Colorectal Liver Metastases

Switzerland, France, Spain
Paul Monk
Genentech, Inc.

Terminated

Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer

Kidney Cancer

United States
Genentech, Inc.

Completed

A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study

Breast Cancer | Colorectal Cancer | Metastases
Genentech, Inc.

Completed

A Study to Evaluate Avastin in Combination With Standard Chemotherapy to Treat Colorectal Cancer

Colorectal Cancer
Peking University

Unknown

Phase I Trial of Intraperitoneal Bevacizumab in Refractory Malignant Ascites

Refractory Malignant Ascites

China
LiNanlin,Ph.D, Chief Physician,Clinical Professor
Roche Pharma AG

Unknown

Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy (BIBC)

Breast Cancer | Bevacizumab | Neoadjuvant Chemotherapy | Molecular Targeted Therapy

China
Shahid Beheshti University of Medical Sciences

Completed

Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial

Retinal Disease

Iran, Islamic Republic of
Grewal Eye Institute

Unknown

Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery

Glaucoma

India

3

Subscribe